Mitochondria in nonalcoholic fatty liver disease

Sayeed, 2002, Mitochondrial dysfunction in sepsis: a familiar song with new lyrics, Crit Care Med, 30, 2780, 10.1097/00003246-200212000-00030

Mahler, 1997, Fulminant liver failure in association with the emetic toxin of Bacillus cereus, N Engl J Med, 336, 1142, 10.1056/NEJM199704173361604

Jacobsen, 2001, Reduced mitochondrial adenosine triphosphate synthesis in skeletal muscle in patients with Child-Pugh Class B and C cirrhosis, Hepatology, 34, 7, 10.1053/jhep.2001.25451

Brealey, 2002, Association between mitochondrial dysfunction and severity and outcome of septic shock, Lancet, 360, 219, 10.1016/S0140-6736(02)09459-X

DiMauro, 2003, Mitochondrial respiratory-chain diseases, N Engl J Med, 348, 2656, 10.1056/NEJMra022567

Carrozzo, 1998, Multiple mtDNA deletions features in autosomal dominant and recessive diseases suggest distinct pathogeneses, Neurology, 50, 99, 10.1212/WNL.50.1.99

Hoek, 2002, Alcohol and mitochondria: a dysfunctional relationship, Gastroenterology, 122, 2049, 10.1053/gast.2002.33613

Gray, 1999, Mitochondrial evolution, Science, 283, 1476, 10.1126/science.283.5407.1476

Green, 1998, Mitochondria and apoptosis, Science, 281, 1309, 10.1126/science.281.5381.1309

Marsman, 1996, Use of fatty donor liver is associated with diminished early patient and graft survival, Transplantation, 62, 1246, 10.1097/00007890-199611150-00011

Masubuchi, 2002, Role of mitochondrial permeability transition in diclofenac-induced hepatocyte injury in rats, Hepatology, 35, 544, 10.1053/jhep.2002.31871

Berson, 1998, Steatohepatitis inducing drugs cause mitochondrial dysfunction and lipid peroxidation in rat hepatocytes, Gastroenterology, 114, 764, 10.1016/S0016-5085(98)70590-6

Caldwell, 2002, Subacute liver failure in obese women, Am J Gastroenterol, 97, 2058, 10.1111/j.1572-0241.2002.05922.x

Bereiter-Hahn, 1994, Dynamics of mitochondria in living cells: shape changes, dislocations, fusion and fission of mitochondria, Microsc Res Tech, 27, 198, 10.1002/jemt.1070270303

Phillips, 1987

Fletcher, 1991, Markers of chronic alcohol ingestion in patients with nonalcoholic steatohepatitis: an aid to diagnosis, Hepatology, 13, 455, 10.1002/hep.1840130312

Kuroiwa, 1994, Molecular and cellular mechanisms of mitochondrial nuclear division and mitochondriokinesis, Microsc Res Tech, 27, 220, 10.1002/jemt.1070270304

Lea, 1994, Variations in mitochondrial ultrastructure and dynamics observed by high resolution scanning electron microscopy (HRSEM), Microsc Res Tech, 27, 269, 10.1002/jemt.1070270402

Di Donato, 2000, Disorders related to mitochondrial membranes: pathology of the respiratory chain and neurodegeneration, J Inherit Metab Dis, 23, 247, 10.1023/A:1005684029429

Lehmann, 2000, Gene delivery of Cu/Zn-superoxide dismutase improves graft function after transplantation of fatty livers in the rat, Hepatology, 32, 1255, 10.1053/jhep.2000.19814

Dianzani, 1954, Uncoupling of oxidative phosphorylation in mitochondria from fatty livers, Biochim Biophys Acta, 14, 514, 10.1016/0006-3002(54)90232-2

Dianzani, 1957, The content of adenosine polyphosphates in fatty livers, Biochem J, 65, 116, 10.1042/bj0650116

Sternlieb, 1968, Mitochondrial and fatty changes in hepatocytes of patients with Wilson's Disease, Gastroenterology, 55, 354, 10.1016/S0016-5085(19)34045-4

Chedid, 1986, Significance of megamitochondria in alcoholic liver disease, Gastroenterology, 90, 1858, 10.1016/0016-5085(86)90253-2

Caldwell, 1999, Mitochondrial abnormalities in NASH, J Hepatol, 31, 430, 10.1016/S0168-8278(99)80033-6

Sanyal, 2001, Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities, Gastroenterology, 120, 1183, 10.1053/gast.2001.23256

Sternlieb, 1969, Optical diffraction studies of crystalline structures in electron micrographs, J Cell Biol, 43, 448, 10.1083/jcb.43.3.448

Candipan, 1984, An analysis of the contribution of the preparatory techniques to the appearance of condensed and orthodox conformations of liver mitochondria, J Ultrastructure Res, 89, 281, 10.1016/S0022-5320(84)80044-1

Schmucker, 1978, Stereological analysis of hepatic fine structure in the Fischer 344 rat, J Cell Biol, 78, 319, 10.1083/jcb.78.2.319

Caldwell, 2001, A pilot study of a thiazolidinedione, troglitazone, in nonalcoholic steatohepatitis, Am J Gastroenterol, 96, 519, 10.1111/j.1572-0241.2001.03553.x

Williams, 1998, X-ray diffraction studies of the structural organization of prolamellar bodies isolated from Zea mays, FEBS Lett, 422, 252, 10.1016/S0014-5793(98)00019-2

Deng, 2002, Fasting induces cyanide-resistant respiration and oxidative stress in the amoeba Chaos carolinensis : implcations for the cubic structural transition in mitochondrial membranes, Protoplasm, 219, 160, 10.1007/s007090200017

Spycher, 1968, Kristalloide Einschlusse in menschlichen Lebermitochondrien, Virch Arch Abt B Zellpath, 1, 211, 10.1007/BF02893718

Wolf, 1999, DNA protection by stress-induced biocrystallization, Nature, 400, 83, 10.1038/21918

Petersen, 1977, Ultrastructure of periportal and centrilobular hepatocytes in human fatty liver of various aetiology, Acta Path Microbiol Scand, 85, 421

Hoffsten, 1962, Formation of “lipid peroxide” under conditions which lead to swelling and lysis of rat liver mitochondria, Biochem Biophys Res Commun, 7, 276, 10.1016/0006-291X(62)90190-0

Le, 2004, The zonal distribution of megamitochondria with crystalline inclusions in nonalcoholic steatohepatitis, Hepatology, 39, 1423, 10.1002/hep.20202

Stadhouders, 1990, Biochemical nature of mitochondrial crystals, J Neurol Sci, 98, 304

Dianzani, 1956, The effects of some inhibitors of oxidative phosphorylation on the morphology and enzymatic activities of mitochondria, Biochem J, 62, 205, 10.1042/bj0620205

Krahenbuhl, 1993, Alterations in mitochondrial function and morphology in chronic liver disease: pathogenesis and potential for therapeutic intervention, Pharmacol Ther, 60, 1, 10.1016/0163-7258(93)90020-E

Vendemiale, 2001, Mitochondrial oxidative injury and energy metabolism alteration in rat fatty liver: effect of the nutritional status, Hepatology, 33, 808, 10.1053/jhep.2001.23060

Junnila, 2000, Reduction of carbon tetrachloride induced hepatotoxic effects by oral administration of betaine in male Han-Wistar rats: a morphometric histologic study, Veterinary Med, 37, 231

Lehman, 2000, Gene delivery of Cu/Zn-superoxide dismutase improves graft function after transplantation of fatty liver in the rat, Hepatology, 32, 1255, 10.1053/jhep.2000.19814

Trevasani, 1996, The use of donor fatty livers for liver transplantation: a challenge or a quagmire, J Hepatol, 22, 114, 10.1016/S0168-8278(96)80195-4

Perez-Carrera, 1999, Activity of the mitochondrial respiratory chain enzymes is decreased in the liver of patients with nonalcoholic steatohepatitis, Hepatology, 30, 379A

Cortez-Pinto, 1999, Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis: a pilot study, JAMA, 282, 1659, 10.1001/jama.282.17.1659

Kiessling, 1971, Ethanol and the human liver- structural and metabolic changes in liver mitochondria, Cytobiologie, 4, 339

Chavin, 1999, Obesity induces expression of uncoupling protein-2 in hepatocytes and promotes liver ATP depletion, J Biol Chem, 274, 5692, 10.1074/jbc.274.9.5692

Diehl, 1999, Mitochondrial uncoupling: role of uncoupling protein anion carriers and relationship to thermogenesis and weight control, “the benefits of losing control, J Bioenerg Biomembr, 31, 493, 10.1023/A:1005452624640

Baffy, 2002, Obesity-related fatty liver is unchanged in mice deficient for mitochondrial UCP-2, Hepatology, 35, 753, 10.1053/jhep.2002.32028

Pessayre, 2002, Nonalcoholic steatosis and steatohepatitis V. Mitochondrial dysfunction in steatohepatitis, Am J Physiol Gastrointest Liver Physiol, 282, G193, 10.1152/ajpgi.00426.2001

Fournier, 1997, Relationship between storage and secretion of hepatic lipids in two breeds of geese with different susceptibility to liver steatosis, Poult Sci, 76, 599, 10.1093/ps/76.4.599

Krugner-Higby, 2000, Type 2 diabetes mellitus, hyperlipidemia, and extremity lesions in California mice (Peromyscus californicus) fed commercial mouse diets, Comp Med, 50, 412

Silva, 2003, The thermogenic effect of thyroid hormone and its clinical implications, Ann Intern Med, 139, 205, 10.7326/0003-4819-139-3-200308050-00018

Dulloo, 2002, A sympathetic defense against obesity, Science, 297, 780, 10.1126/science.1074923

Bachman, 2002, betaAR signaling required for diet-induced thermogenesis and obesity resistance, Science, 297, 843, 10.1126/science.1073160

Struben, 2000, Familial patterns of non-alcoholic steatohepatitis (NASH) and cryptogenic cirrhosis, Am J Med, 108, 9, 10.1016/S0002-9343(99)00315-0

Willner, 2001, Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency and severity of disease, Am J Gastroenterol, 96, 2957, 10.1111/j.1572-0241.2001.04667.x

Caldwell, 2002, Are NASH and cryptogenic cirrhosis under diagnosed in African Americans?, Am J Gastroenterol, 97, 1496, 10.1111/j.1572-0241.2002.05795.x

Hunt, 2003, Ethnic differences in the prevalence of NASH in the United States—findings from the NHANES III study [abstract], Gastroenterology, 124, A-702, 10.1016/S0016-5085(03)83547-3

Schapira, 1997, Mitochondrial disorders: an overview, J Bioenerg Biomembr, 29, 105, 10.1023/A:1022626812008

Schon, 1997, Mitochondrial DNA mutations and pathogenesis, J Bioenerg Biomembr, 29, 131, 10.1023/A:1022685929755

Johns, 1995, Mitochondrial DNA and disease, N Engl J Med, 333, 638, 10.1056/NEJM199509073331007

Wallace, 1999, Mitochondrial diseases in mouse and man, Science, 283, 1482, 10.1126/science.283.5407.1482

Shigenaga, 1994, Oxidative damage and mitochondrial decay in aging, Proc Natl Acad Sci USA, 91, 10771, 10.1073/pnas.91.23.10771

Mansouri, 1999, An alcoholic binge causes massive degradation of hepatic mitochondrial DNA in mice, Gastroenterology, 117, 181, 10.1016/S0016-5085(99)70566-4

Fromenty, 1995, Hepatic mitochondrial DNA deletion in alcoholics: association with microvesicular steatosis, Gastroenterology, 108, 193, 10.1016/0016-5085(95)90024-1

Mansouri, 1997, Premature oxidative aging of hepatic mitochondrial DNA in Wilson's disease, Gastroenterology, 113, 599, 10.1053/gast.1997.v113.pm9247482

Cote, 2002, Changes in mitochondrial DNA as a marker of nucleoside toxicity in HIV infected patients, N Engl J Med, 346, 811, 10.1056/NEJMoa012035

Bohan, 2000, Mitochondrial DNA abnormalities without significant deficiency of intramitochondrial fatty acid beta oxidation enzymes in a well defined subgroup of patients with nonalcoholic steatohepatitis [abstract], Hepatology, 32, 387A

Carrozzo, 1998, Multiple mtDNA deletions features in autosomal dominant and recessive diseases suggest distinct pathogeneses, Neurology, 50, 99, 10.1212/WNL.50.1.99

Hinokio, 1995, A new mitochondrial DNA deletion associated with diabetic amyotrophy, diabetic myoatrophy, and diabetic fatty liver, Muscle Nerve, 3, S142, 10.1002/mus.880181428

Feliciani, 1999, Madelung's disease: inherited from an ancient Mediterranean population?, N Engl J Med, 340, 1481, 10.1056/NEJM199905133401906

Vila, 2000, Uncoupling protein-1 m RNA expression in lipomas from patients bearing pathogenic mitochondrial DNA mutations, Biochem Biophys Res Commun, 278, 800, 10.1006/bbrc.2000.3828

Guillausseau, 2001, Maternally inherited diabetes and deafness: a multicenter study, Ann Intern Med, 134, 721, 10.7326/0003-4819-134-9_Part_1-200105010-00008

Kadowaki, 1993, Mitochondrial gene mutation and insulin-deficient type of diabetes mellitus, Lancet, 341, 893, 10.1016/0140-6736(93)93101-6

Minana, 2002, Mitochondrial oxidative stress and CD95 ligand: a dual mechanism for hepatocyte apoptosis in chronic alcoholism, Hepatology, 35, 1205, 10.1053/jhep.2002.32969

Feldsteine, 2003, Hepatocyte apoptosis in patients with non-alcoholic steatohepatitis. Quantification and clinical relevance, Gastroenterology, 124, 703A, 10.1016/S0016-5085(03)83556-4

Feldman, 2000, Opening of the mitochondrial permeability transition pore causes matrix expansion and outer membrane rupture in FAS-mediated hepatic apoptosis in mice, Hepatology, 31, 674, 10.1002/hep.510310318

Lemasters, 1998, Mitochondrial permeability transition pore: from biochemical curiosity to pathophysiological mechanism, Gastroenterology, 115, 783, 10.1016/S0016-5085(98)70160-X

Rashid, 1999, Mitochondrial proteins that regulate apoptosis and necrosis are induced in mouse fatty liver, Hepatology, 29, 1131, 10.1002/hep.510290428

Selzer, 2000, Mechanisms of ischemic injury are different in the steatotic and normal rat liver, Hepatology, 32, 1280, 10.1053/jhep.2000.20528

Calle, 2003, Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults, N Engl J Med, 348, 1625, 10.1056/NEJMoa021423

Powell, 1990, The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years, Hepatology, 11, 74, 10.1002/hep.1840110114

Cotrim, 2000, Nonalcoholic steatohepatitis and hepatocellular carcinoma: natural history?, Am J Gastro, 95, 3018, 10.1111/j.1572-0241.2000.03241.x

Zen, 2001, Hepatocellualr carcinoma arising in non-alcoholic steatohepatitis, Pathol Int, 51, 127, 10.1046/j.1440-1827.2001.01174.x

Marrero, 2002, NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States, Hepatology, 36, 1349, 10.1053/jhep.2002.36939

Ratzui, 2002, Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis, Hepatology, 35, 1485, 10.1053/jhep.2002.33324

Bugianesi, 2002, Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma, Gastroenterology, 123, 134, 10.1053/gast.2002.34168

Nair, 2002, Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis?, Hepatology, 36, 150, 10.1053/jhep.2002.33713

Yang, 2001, Hepatic hyperplasia in noncirrhotic fatty livers: is obesity-related hepatic steatosis a premalignant condition?, Cancer Res, 61, 5016

Wiseman, 1996, Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer, Biochem J, 313, 17, 10.1042/bj3130017

Cerutti, 1994, Oxy-radicals and cancer, Lancet, 344, 862, 10.1016/S0140-6736(94)92832-0

Hu, 2002, The major lipid peroxidation product, trans-4-hydroxy-2 nonenal, preferentially forms DNA adducts at codon 249 of human p53 gene, a unique mutational hotspot in hepatocellular carcinoma, Carcinogenesis, 23, 1781, 10.1093/carcin/23.11.1781

Hussain, 1994, Oxy-radical induced mutagenesis of hotspot codons 248 and 249 of the human p53 gene, Oncogene, 9, 2277

Moriya, 2001, Oxidative stress in the absence of inflammation in a mouse model for hepatitis C virus-associated hepatocarcinogenesis, Cancer Res, 61, 4365

Hensley, 2000, Dietary choline restriction causes complex I dysfunction and increased H2O2 generation in liver mitochondria, Carcinogenesis, 21, 983, 10.1093/carcin/21.5.983

Cortez-Pinto, 1999, Non-alcoholic fatty liver: another feature of the metabolic syndrome, Clin Nutr, 18, 353, 10.1016/S0261-5614(99)80015-6

Marchesini, 2003, Nonalcoholic fatty liver, steatohepatitis and the metabolic syndrome, Hepatology, 37, 917, 10.1053/jhep.2003.50161

Powell, 1989, Steatohepatitis associated with limb lipodystrophy, Gastroenterology, 97, 1022, 10.1016/0016-5085(89)91513-8

Degoul, 2001, Homozygosity for alanine in the mitochondrial targeting sequence of manganese superoxide dismutase and risk for severe alcoholic liver disease, Gastroenterology, 120, 1468, 10.1053/gast.2001.24051

Petersen, 2003, Mitochondrial dysfunction in the elderly: possible role in insulin resistance, Science, 300, 1140, 10.1126/science.1082889

Borkman, 1993, The relationship between insulin sensitivity and the fatty-acid composition of skeletal muscle phospholipids, N Engl J Med, 328, 238, 10.1056/NEJM199301283280404

Sreekumar, 2003, Hepatic gene expression in histologically progressive nonalcoholic steatohepatitis, Hepatology, 38, 244, 10.1053/jhep.2003.50290

Krahenbuhl, 2001, Alcohol-induced myopathy: what is the role of mitochondria?, Hepatology, 34, 210, 10.1053/jhep.2001.26307

Hoppeler, 1985, Endurance training in humans: aerobic capacity and structure of skeletal muscle, J Appl Physiol, 59, 320, 10.1152/jappl.1985.59.2.320

Fernandez, 1997, Steatosis and collagen content in experimental liver cirrhosis are affected by dietary monosaturated and polyunsaturated fatty acids, Scand J Gastroenterol, 32, 350, 10.3109/00365529709007683

Tsuboyama-Kasaoka, 2000, Conjugated linoleic acid supplementation reduces adipose tissue by apoptosis and develops lipodystrophy in mice, Diabetes, 49, 1534, 10.2337/diabetes.49.9.1534

Kurihara, 1994, Role of eicosapentanoic acid in lipid metabolism in the liver with special reference to experimental fatty liver, Clin Ther, 16, 830

Nanji, 1995, Dietary saturated fatty acids: a novel treatment for alcoholic liver disease, Gastroenterology, 109, 547, 10.1016/0016-5085(95)90344-5

Caldwell, 2001, A pilot study of a thiazolidinedione, troglitazone, in nonalcoholic steatohepatitis, Am J Gastroenterol, 96, 519, 10.1111/j.1572-0241.2001.03553.x

Acosta, 2001, The use of pioglitazone in nonalcoholic steatohepatitis [abstract], Gastroenterology, 120, 546, 10.1016/S0016-5085(08)82715-1

Sanyal, 2002, A randomized controlled pilot study of pioglitazone and vitamin E versus vitamin E for non-alcoholic steatohepatitis [abstract], Hepatology, 36, 382

Neuschwander-Tetri, 2002, Histologic improvement in NASH following increased insulin sensitivity with the PPAR-γ ligand rosiglitazone for 48 weeks[abstract], Hepatology, 36, 379

Phillips, 2002, Statin-associated myopathy with normal creatine kinase levels, Ann Intern Med, 137, 581, 10.7326/0003-4819-137-7-200210010-00009

Caldwell, 2003, The liver and statin drug therapy: uncertain navigation in the sea of risk-benefit, Pharmacoepidemiology, 12, 1